Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:TOM2 - NL0013332471 - Common Stock

5.34 EUR
+0.05 (+0.95%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

TOM2 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 116 industry peers in the Software industry. TOM2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TOM2 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TOM2 has reported negative net income.
TOM2 had a positive operating cash flow in the past year.
In the past 5 years TOM2 always reported negative net income.
In multiple years TOM2 reported negative operating cash flow during the last 5 years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of TOM2 (-2.47%) is worse than 62.93% of its industry peers.
With a Return On Equity value of -13.12%, TOM2 is not doing good in the industry: 70.69% of the companies in the same industry are doing better.
The Return On Invested Capital of TOM2 (2.14%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.47%
ROE -13.12%
ROIC 2.14%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With a Operating Margin value of 2.34%, TOM2 perfoms like the industry average, outperforming 47.41% of the companies in the same industry.
The Gross Margin of TOM2 (88.02%) is better than 83.62% of its industry peers.
TOM2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) N/A
GM 88.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TOM2 is destroying value.
Compared to 1 year ago, TOM2 has less shares outstanding
The number of shares outstanding for TOM2 has been reduced compared to 5 years ago.
TOM2 has a worse debt/assets ratio than last year.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of TOM2 is 4.47, which is a neutral value as it means it would take TOM2, 4.47 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of TOM2 (4.47) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.23 indicates that TOM2 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, TOM2 is in line with its industry, outperforming 57.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.47
Altman-Z N/A
ROIC/WACC0.28
WACC7.67%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.71 indicates that TOM2 should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.71, TOM2 is doing good in the industry, outperforming 66.38% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that TOM2 should not have too much problems paying its short term obligations.
The Quick ratio of TOM2 (1.67) is better than 68.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.67
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

TOM2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.24%, which is quite impressive.
The Revenue has decreased by -1.70% in the past year.
TOM2 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.90% yearly.
EPS 1Y (TTM)27.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%

3.2 Future

The Earnings Per Share is expected to grow by 70.18% on average over the next years. This is a very strong growth
TOM2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.40% yearly.
EPS Next Y35.71%
EPS Next 2Y109.59%
EPS Next 3Y70.18%
EPS Next 5YN/A
Revenue Next Year-2.98%
Revenue Next 2Y-0.71%
Revenue Next 3Y0.5%
Revenue Next 5Y7.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TOM2. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 23.44, which indicates a rather expensive current valuation of TOM2.
TOM2's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TOM2 is cheaper than 67.24% of the companies in the same industry.
TOM2 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 23.44
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOM2 is valued cheaply inside the industry as 90.52% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as TOM2.
Industry RankSector Rank
P/FCF 77.33
EV/EBITDA 6.39
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TOM2's earnings are expected to grow with 70.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.59%
EPS Next 3Y70.18%

0

5. Dividend

5.1 Amount

No dividends for TOM2!.
Industry RankSector Rank
Dividend Yield N/A

TOMTOM NV

AMS:TOM2 (11/28/2025, 7:00:00 PM)

5.34

+0.05 (+0.95%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-14 2025-10-14
Earnings (Next)02-02 2026-02-02/amc
Inst Owners18.07%
Inst Owner ChangeN/A
Ins Owners51.4%
Ins Owner ChangeN/A
Market Cap667.50M
Revenue(TTM)565.73M
Net Income(TTM)-17.25M
Analysts76
Price Target6.09 (14.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.16%
PT rev (3m)11.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.44
P/S 1.18
P/FCF 77.33
P/OCF 18.76
P/B 5.08
P/tB N/A
EV/EBITDA 6.39
EPS(TTM)-0.15
EYN/A
EPS(NY)0.23
Fwd EY4.27%
FCF(TTM)0.07
FCFY1.29%
OCF(TTM)0.28
OCFY5.33%
SpS4.53
BVpS1.05
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE -13.12%
ROCE 2.86%
ROIC 2.14%
ROICexc 5.05%
ROICexgc N/A
OM 2.34%
PM (TTM) N/A
GM 88.02%
FCFM 1.53%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score7
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.47
Debt/EBITDA 0.86
Cap/Depr 120.31%
Cap/Sales 4.76%
Interest Coverage 7.62
Cash Conversion 99.82%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.67
Altman-Z N/A
F-Score7
WACC7.67%
ROIC/WACC0.28
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y35.71%
EPS Next 2Y109.59%
EPS Next 3Y70.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%
Revenue Next Year-2.98%
Revenue Next 2Y-0.71%
Revenue Next 3Y0.5%
Revenue Next 5Y7.4%
EBIT growth 1Y153.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.14%
EBIT Next 3Y87.31%
EBIT Next 5YN/A
FCF growth 1Y260.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y643.88%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%

TOMTOM NV / TOM2.AS FAQ

What is the ChartMill fundamental rating of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TOM2.AS.


What is the valuation status of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to TOMTOM NV (TOM2.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for TOMTOM NV?

TOMTOM NV (TOM2.AS) has a profitability rating of 2 / 10.


Can you provide the financial health for TOM2 stock?

The financial health rating of TOMTOM NV (TOM2.AS) is 4 / 10.


What is the earnings growth outlook for TOMTOM NV?

The Earnings per Share (EPS) of TOMTOM NV (TOM2.AS) is expected to grow by 35.71% in the next year.